In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Taysha Gene Therapies Inc’s stock clocked out at $2.00, down -18.70% from its previous closing price of $2.46. In other words, the price has decreased by -$18.70 from its previous closing price. On the day, 8.49 million shares were traded.
Ratios:
To gain a deeper understanding of TSHA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 49.23 while its Price-to-Book (P/B) ratio in mrq is 5.73.
Stock Price History:
Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is 21.48%, while the 200-Day Moving Average is calculated to be 4.29%.
Shares Statistics:
A total of 204.94M shares are outstanding, with a floating share count of 165.06M. Insiders hold about 19.51% of the company’s shares, while institutions hold 77.26% stake in the company.
